← All themes

Genomics & Gene Editing

Genomics reads the genetic code and gene editing rewrites it, which can turn an inherited disease from a lifelong condition into a single treatment. Sequencing cost has fallen far enough to make study at population scale routine.

199 stocks

Gene Therapy

#	Name	Funds holding	Growth	Growth %	Fund value
26	26 Regenxbio RGNX $454M	108	+19	+21%	$718M
27	ATHX 27 DELISTED Athersys, Inc. Common Stock ATHX	105	+8	+8%	$43.9M
28	SIOX 28 DELISTED Sio Gene Therapies Inc. Common Stock SIOX	105	-9	-8%	$528M
29	NVTA 29 DELISTED Invitae Corporation NVTA	99	+5	+5%	$341M
30	30 Voyager Therapeutics VYGR $124M	98	+23	+31%	$418M
31	31 Abeona Therapeutics ABEO $249M	93	+18	+24%	$464M
32	BLCM 32 DELISTED Bellicum Pharmaceuticals, Inc. BLCM	91	+3	+3%	$154M
33	33 Atara Biotherapeutics ATRA $96M	86	+4	+5%	$542M
34	34 CRISPR Therapeutics CRSP $4.86B	83	+19	+30%	$293M
35	NSTG 35 DELISTED NanoString Technologies, Inc. NSTG	82	-10	-11%	$175M
36	36 Standard BioTools LAB $248M	81	+1	+1%	$217M
37	37 Veracyte VCYT $3.5B	79	-8	-9%	$158M
38	38 Fate Therapeutics FATE $232M	78	+4	+5%	$216M
39	39 Lakefront Biotherapeutics American Depositary Shares LKFT $1.93B	77	+8	+12%	$932M
40	40 Arrowhead Research ARWR $8.25B	76	+21	+38%	$86M
41	ISEE 41 DELISTED IVERIC bio, Inc. Common Stock ISEE	75	+8	+12%	$68.1M
42	42 Wave Life Sciences WVE $609M	73	+15	+26%	$780M
43	ADAP 43 DELISTED Adaptimmune Therapeutics ADAP	71	+4	+6%	$348M
44	44 Invesco Biotechnology & Genome ETF PBE $421M	69	+9	+15%	$52.3M
45	45 DELISTED Adverum Biotechnologies ADVM	65	+7	+12%	$67.3M
46	46 Cartesian Therapeutics RNAC $192M	63	+10	+19%	$107M
47	AGTC 47 DELISTED Applied Genetic Technologies Corporation AGTC	62	-5	-7%	$30M
48	48 Fortress Biotech FBIO $63.4M	62	+4	+7%	$24.4M
49	49 uniQure QURE $1.45B	62	+26	+72%	$267M
50	50 CareDx CDNA $3.35B	59	+32	+119%	$110M